enGene Therapeutics Inc. 8-K

What Happened
enGene Therapeutics Inc. (formerly enGene Holdings Inc.) filed a notice of alteration with the British Columbia Registrar of Companies on April 6, 2026, and the name change became effective April 8, 2026. The board amended the company’s articles to reflect the new corporate name, and the company issued a press release on April 7, 2026 announcing the change.

Key Details

• Notice of Alteration was filed April 6, 2026; name change effective April 8, 2026.
• Articles were amended only to update the corporate name to enGene Therapeutics Inc.; no other article changes.
• Common shares and warrants will continue to trade on Nasdaq under the same tickers: shares "ENGN" and warrants "ENGNW".
• Exhibits filed/furnished include the Notice of Alteration and amended Articles (Exs. 3.1, 3.2) and the April 7, 2026 press release (Ex. 99.1).

Why It Matters
This is a formal, administrative change to the company’s corporate name and articles; it does not alter the company’s securities, share structure, or trading symbols. For investors, holdings and warrant rights remain the same and trading on Nasdaq will continue under the existing tickers, so no action is required solely because of this filing.